BPC 157 (Body Protecting Compound 157 link:https://www.bloomtechz.com/synthetic-chemical/peptide/bpc-157-powder-cas-137525-51-0.html) is a peptide compound composed of 15 amino acids with various chemical properties. See the following description for details:
1. Molecular formula and structure:
The molecular formula of BPC 157 is C62H98N16O22, and its structure consists of 15 amino acid residues. It includes amino acids such as alanine, proline, tryptophan, aspartic acid, phenylalanine, and leucine.
2. Solubility:
BPC 157 has good solubility in water, and can also be dissolved in some organic solvents, such as DMSO (dimethyl sulfoxide), methanol and ethanol, etc. However, in common organic solvents, the solubility may be lower.
3. Stability:
BPC 157 has certain stability to temperature and acidity and alkalinity. It can exist relatively stably under common experimental conditions (such as room temperature and acid-base neutral pH). However, under extreme conditions, such as high temperature, strong acid or strong alkali, BPC 157 may degrade.
4. Optical activity:
BPC 157 is a chiral molecule with two enantiomers (D-form and L-form). These enantiomers may differ slightly in chemical properties, but differences in biological activity are still being studied.
5. pH dependence:
The solution properties of BPC 157 are affected by pH. In different pH ranges, BPC 157 may undergo ionization and dehydration reactions, thereby affecting its solubility and stability.
6. Biochemical reactions:
BPC 157 may have some reactions in certain biochemical environments. For example, it may form complexes with metal ions, participate in redox reactions, etc. These reactions may affect their biological activity and pharmacological properties.
It should be pointed out that the above is just an overview of some basic chemical properties of BPC 157. Detailed description of chemical properties requires more experimental data and in-depth research. At the same time, according to these basic chemical properties and various literature references, we have used the following methods to successfully produce this product, and will continue to optimize the synthetic route in order to improve the purity of the product. Currently, BPC 157 is mainly synthesized by chemical methods, including solid-phase synthesis and liquid-phase synthesis.
1. Solid phase synthesis method:
Solid-phase synthesis is a method of gradually building peptide chains from the N-terminus to the C-terminus. The following are the solid phase synthesis steps of BPC 157:
- First, choose an appropriate protecting group to protect the amino acid functional groups in the peptide chain.
- Link the first amino acid to a solid support (such as resin) and immobilize it in the reaction vessel.
- Sequentially add amino acids protected by other protecting groups and link them to the existing peptide chains using specific coupling reagents.
- Wash and deprotect the reaction after each step.
- When the peptide chain synthesis is complete, it is dissociated from the solid phase support.
- Finally, pure BPC 157 is obtained through steps of reduction, cleavage and purification.
2. Liquid phase synthesis method:
Solution-phase synthesis is a method by which peptide chains are gradually built up in solution. The following are the liquid phase synthesis steps of BPC 157:
- First, choose an appropriate protecting group to protect the amino acid functional groups in the peptide chain.
- Add the first amino acid to the reaction vessel and allow it to undergo a condensation reaction with the next amino acid using an activator such as DCC and a catalyst such as DMAP.
- Add amino acids protected by other protecting groups in sequence, and carry out condensation reaction until a complete peptide chain is synthesized.
- After each step, washing and deprotection are required.
- After the synthesis of the peptide chain is completed, pure BPC 157 is obtained through reduction, cleavage, purification and other steps.
In summary, solid-phase synthesis and liquid-phase synthesis are one of the common methods for synthesizing BPC 157. These methods require skilled laboratory manipulation and knowledge of chemistry. Please note that before performing any chemical synthesis, please ensure that you have sufficient knowledge and professional guidance, and follow relevant safety procedures.
Below is a detailed description of the discovery history of BPC 157.
1. Discover the background:
BPC 157 was first discovered by a team of researchers in Croatia in the late 1970s. At the time, the research group was working on a treatment for stomach ulcers. They selected an antibiotic called "Pliva" (PL 14736) for research and accidentally discovered its potential anti-ulcer effect.
2. Isolation and synthesis of BPC 157:
In further studies of PL 14736, the researchers succeeded in isolating a peptide compound from the gastric mucosa, which is known today as BPC 157. Subsequently, they conducted in vivo and in vitro pharmacological studies on BPC 157 and found that it has various abilities to protect, repair and regenerate tissues.
3. Anti-ulcer and protection of gastric mucosa:
Initially, BPC 157 was mainly studied for the treatment of gastric ulcers. Studies have found that BPC 157 can protect gastric mucosa from damage by promoting gastric mucosal repair, preventing ulcer formation, and providing antioxidant and anti-inflammatory effects. These protective effects are considered to be related to the role of BPC 157 in regulating various biological signaling pathways and promoting cell proliferation, angiogenesis, and collagen synthesis.
4. Biological activity and therapeutic potential:
As the biological activity of BPC 157 was studied in depth, researchers began to explore its potential in the treatment of other diseases and trauma. BPC 157 has been found to promote muscle and bone tissue repair, protect liver function, improve cardiovascular health, reduce inflammation, and promote nerve regeneration.
5. Research progress and clinical application:
With the deepening of the research on BPC 157, the peptide compound has been widely studied in different animal models and human applications. Studies have shown that BPC 157 has the potential to treat muscle damage, ligament damage, ulcerative colitis, liver disease, heart disease and neurodegenerative diseases.
Although BPC 157 shows broad therapeutic potential, more studies are still needed to verify its safety and efficacy and provide more evidence for its clinical application.
To sum up, BPC 157 was discovered by accident by a team of researchers in Croatia while studying anti-ulcer drugs. Subsequent studies revealed the potential of BPC 157 in gastric mucosal protection and many other tissue protection and repair. Since its discovery, BPC 157 has been under continuous scientific research to explore its role and application prospects in the treatment of different diseases and injuries.